What is regenerative medicine, how can it change healthcare and what type of innovation & business opportunities does it provide?
By definition, regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs.
Join us for the May edition of Health Tuesday to network and learn more about Finnish innovation in regenerative medicine!
Agenda
8.00 Opening Words
Sampo Sammalisto, Head of Personalized Health Finland, Business Finland
8.05 3D bioprinting – the future of tailor-made medicine
Susanna Miettinen, Group leader, Adult Stem Cell Group
8.20 StemSight – stem cell based therapies for blindness
Laura Koivusalo, CEO, Stemsight
8.35 EpiHeart’s approaches for cardiac regeneration and heart failure treatment
Kai Kronström, CEO, Co-founder, EpiHeart
8.50 Q&A and closing words
Sampo Sammalisto, Head of Personalized Health Finland, Business Finland
9.00 Health Tuesday event ends
9.15 Market opportunities Roundtable: Singapore opportunities and market entry support
Moderated by Riku Mäkelä, Team Finland Coordinator, Singapore
With an ageing population and as manpower resources tighten, more innovative solutions will be needed to improve the quality of Singapore’s healthcare provision and delivery while keeping healthcare affordable and accessible for all. Singaporean healthcare providers are actively seeking innovative technology-enabled solutions to transform their public healthcare system and address future healthcare needs for their citizens. Singapore is a regional base for tens of thousands of companies and nearby countries with more than 600 million people look at Singapore as a benchmark. Join this roundtable to discuss opportunities in Singapore and the South East Asian region with our expert in the region!
10.15 Roundtable session ends
Please find the presentations below:
Opening words
3D bioprinting – the future of tailor-made medicine
EpiHeart’s approaches for cardiac regeneration and heart failure treatment
